Risky decision-making in individuals with substance use disorder: A meta-analysis and meta-regression review.


Journal

Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 08 10 2019
accepted: 10 03 2020
pubmed: 5 5 2020
medline: 21 10 2020
entrez: 5 5 2020
Statut: ppublish

Résumé

This review aims to identify whether risky decision-making is increased in substance users, and the impact of substance type, polysubstance use status, abstinence period, and treatment status on risky decision-making. A literature search with no date restrictions was conducted to identify case-control studies or cross-sectional studies that used behavioral tasks to measure risky decision-making in substance users. A random-effects model was performed. GRADE criteria was used to assess the quality of evidence. 52 studies were enrolled. The result showed that the difference in risky decision-making performance between user groups and control groups was significant (SMD = - 0.590; 95%CI = - 0.849 to - 0.330; p < 0.001; I The results show that substance use is associated with impaired risky decision-making, indicating that interventions targeting risky decision-making in substance users should be developed for relapse prevention and rehabilitation.

Sections du résumé

BACKGROUND BACKGROUND
This review aims to identify whether risky decision-making is increased in substance users, and the impact of substance type, polysubstance use status, abstinence period, and treatment status on risky decision-making.
METHODS METHODS
A literature search with no date restrictions was conducted to identify case-control studies or cross-sectional studies that used behavioral tasks to measure risky decision-making in substance users. A random-effects model was performed. GRADE criteria was used to assess the quality of evidence.
RESULTS RESULTS
52 studies were enrolled. The result showed that the difference in risky decision-making performance between user groups and control groups was significant (SMD = - 0.590; 95%CI = - 0.849 to - 0.330; p < 0.001; I
CONCLUSIONS CONCLUSIONS
The results show that substance use is associated with impaired risky decision-making, indicating that interventions targeting risky decision-making in substance users should be developed for relapse prevention and rehabilitation.

Identifiants

pubmed: 32363438
doi: 10.1007/s00213-020-05506-y
pii: 10.1007/s00213-020-05506-y
doi:

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1893-1908

Subventions

Organisme : National Key R&D Program of China
ID : 2017YFC1310400
Organisme : National Nature Science Foundation
ID : 81771436, U1502228, 81601164
Organisme : Shanghai Municipal Health and Family Planning Commission
ID : 2017ZZ02021
Organisme : Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai
ID : 2017YQ013
Organisme : Shanghai Key Laboratory of Psychotic Disorders
ID : 13DZ2260500
Organisme : Program of Shanghai Academic Research Leader
ID : 17XD1403300

Auteurs

Shujuan Chen (S)

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, China.

Pingyuan Yang (P)

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, China.

Tianzhen Chen (T)

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, China.

Hang Su (H)

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, China.

Haifeng Jiang (H)

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, China.
Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China.

Min Zhao (M)

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, China. drminzhao@gmail.com.
Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China. drminzhao@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH